232 related articles for article (PubMed ID: 15352293)
21. Efficacy of ciclopiroxolamine 1% cream in onychomycosis and tinea pedis.
Wu YC; Chuan MT; Lü YC
Mycoses; 1991; 34(1-2):93-5. PubMed ID: 1833642
[TBL] [Abstract][Full Text] [Related]
22. [Experience with Variotin in clinics, polyclinics and medical practice in Europe].
Rieth H
Mykosen; 1968 Jun; 11(6):471-4. PubMed ID: 4242214
[No Abstract] [Full Text] [Related]
23. Onychomycosis: therapy directed by morphology and mycology.
Barber K; Barber J
Skin Therapy Lett; 2009 Jan; 14(1):1-2. PubMed ID: 19214354
[TBL] [Abstract][Full Text] [Related]
24. Management of onychomycosis and co-existing tinea pedis.
Lipner SR; Scher RK
J Drugs Dermatol; 2015 May; 14(5):492-4. PubMed ID: 25942668
[TBL] [Abstract][Full Text] [Related]
25. Best Evidence Topic report. BET 4. What best scratches the itch?
Grayson A; Mackenzie L
Emerg Med J; 2010 Feb; 27(2):145-6. PubMed ID: 20156874
[No Abstract] [Full Text] [Related]
26. Fifth toenail clinical response to systemic antifungal therapy is not a marker of successful therapy for other toenails with onychomycosis.
Avner S; Nir N; Henri T
J Eur Acad Dermatol Venereol; 2006 Nov; 20(10):1194-6. PubMed ID: 17062030
[TBL] [Abstract][Full Text] [Related]
27. Treatment of tinea nigra with terbinafine.
Shannon PL; Ramos-Caro FA; Cosgrove BF; Flowers FP
Cutis; 1999 Sep; 64(3):199-201. PubMed ID: 10500924
[TBL] [Abstract][Full Text] [Related]
28. Curing onychomycosis: understanding the multitude of variables.
Lagana FJ
Clin Podiatr Med Surg; 2004 Oct; 21(4):555-64, vi. PubMed ID: 15450896
[TBL] [Abstract][Full Text] [Related]
29. [Application of a fungicido-keratolytic lacquer for treatment of fungous diseases of the feet].
Gnuzdev GN
Vestn Dermatol Venerol; 1969 Mar; 43(3):85-8. PubMed ID: 4246619
[No Abstract] [Full Text] [Related]
30. Fungal toenail infections.
Crawford F; Ferrari J
Clin Evid; 2006 Jun; (15):2212-20. PubMed ID: 16973086
[No Abstract] [Full Text] [Related]
31. The truth about toenail fungus.
Johns Hopkins Med Lett Health After 50; 2009 Feb; 20(12):3. PubMed ID: 19241610
[No Abstract] [Full Text] [Related]
32. Athlete's foot and onychomycosis caused by Hendersonula toruloidea.
Abramson C
Cutis; 1990 Aug; 46(2):128-32. PubMed ID: 2145133
[TBL] [Abstract][Full Text] [Related]
33. A pilot evaluation of pulse itraconazole vs. terbinafine for treatment of Candida toenail onychomycosis.
Warshaw EM; Nelson D; Carver SM; Zielke GR; Webster N; Lederle FA; Fett DD
Int J Dermatol; 2005 Sep; 44(9):785-8. PubMed ID: 16135154
[No Abstract] [Full Text] [Related]
34. Efficacy and tolerability of terbinafine 1% emulsion gel in patients with tinea pedis.
Hollmen KA; Kinnunen T; Kiistala U; Väänänen A; Saarelainen IO; De CC; Decroix J; Broeckx W; Karvonen J
J Eur Acad Dermatol Venereol; 2002 Jan; 16(1):87-8. PubMed ID: 11952304
[No Abstract] [Full Text] [Related]
35. A case of onychomycosis due to Aspergillus sydowii diagnosed using DNA sequence analysis.
Takahata Y; Hiruma M; Sugita T; Muto M
Mycoses; 2008 Mar; 51(2):170-3. PubMed ID: 18254756
[TBL] [Abstract][Full Text] [Related]
36. Consumer preferences of antifungal products for treatment and prevention of tinea pedis.
Kang R; Lipner S
J Dermatolog Treat; 2019 Dec; 30(8):745-749. PubMed ID: 30661432
[TBL] [Abstract][Full Text] [Related]
37. Athlete's foot.
Crawford F
Clin Evid; 2005 Dec; (14):2000-5. PubMed ID: 16620478
[No Abstract] [Full Text] [Related]
38. Substantivity of topically applied antifungals on dermatophytic toe webs.
del Rio E
Cutis; 2001 May; 67(5 Suppl):40-1. PubMed ID: 11398270
[No Abstract] [Full Text] [Related]
39. Onychomycosis.
Sinclair R
Aust Fam Physician; 1997 Jul; 26(7):867. PubMed ID: 9232928
[No Abstract] [Full Text] [Related]
40. [A report on the clinical experiences from the comparison of the effectiveness of 0.2% and 0.5% solutions of the antimycotic agent VUFB 9244 (working name Jopargin)].
Klíma J
Cesk Dermatol; 1976 Dec; 51(6):404-6. PubMed ID: 137783
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
